Morepen Laboratories Limited MOREPENLAB.NS Stock
Morepen Laboratories Limited Price Chart
Morepen Laboratories Limited MOREPENLAB.NS Financial and Trading Overview
| Morepen Laboratories Limited stock price | 43.4 INR |
| Previous Close | 30.4 INR |
| Open | 30.5 INR |
| Bid | 29.35 INR x 0 |
| Ask | 29.4 INR x 0 |
| Day's Range | 29.2 - 30.6 INR |
| 52 Week Range | 23.6 - 48.45 INR |
| Volume | 8.37M INR |
| Avg. Volume | 3.62M INR |
| Market Cap | 15B INR |
| Beta (5Y Monthly) | 1.088013 |
| PE Ratio (TTM) | 38.116886 |
| EPS (TTM) | 1.5 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 18, 2002 |
| 1y Target Est | N/A |
MOREPENLAB.NS Valuation Measures
| Enterprise Value | 14B INR |
| Trailing P/E | 38.116886 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0538173 |
| Price/Book (mrq) | 2.0076613 |
| Enterprise Value/Revenue | 0.983 |
| Enterprise Value/EBITDA | 16.344 |
Trading Information
Morepen Laboratories Limited Stock Price History
| Beta (5Y Monthly) | 1.088013 |
| 52-Week Change | -15.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 48.45 INR |
| 52 Week Low | 23.6 INR |
| 50-Day Moving Average | 26.83 INR |
| 200-Day Moving Average | 28.66 INR |
MOREPENLAB.NS Share Statistics
| Avg. Volume (3 month) | 3.62M INR |
| Avg. Daily Volume (10-Days) | 5.8M INR |
| Shares Outstanding | 511.17M |
| Float | 252.68M |
| Short Ratio | N/A |
| % Held by Insiders | 48.22% |
| % Held by Institutions | 0.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 2.71% |
| Operating Margin (ttm) | 4.05% |
| Gross Margin | 31.19% |
| EBITDA Margin | 6.01% |
Management Effectiveness
| Return on Assets (ttm) | 3.30% |
| Return on Equity (ttm) | 5.81% |
Income Statement
| Revenue (ttm) | 14.24B INR |
| Revenue Per Share (ttm) | 28.34 INR |
| Quarterly Revenue Growth (yoy) | -0.89% |
| Gross Profit (ttm) | 4.44B INR |
| EBITDA | 856.67M INR |
| Net Income Avi to Common (ttm) | 386.75M INR |
| Diluted EPS (ttm) | 0.77 |
| Quarterly Earnings Growth (yoy) | -33.10% |
Balance Sheet
| Total Cash (mrq) | 563.05M INR |
| Total Cash Per Share (mrq) | 1.09 INR |
| Total Debt (mrq) | 251.64M INR |
| Total Debt/Equity (mrq) | 3.34 INR |
| Current Ratio (mrq) | 2.354 |
| Book Value Per Share (mrq) | 14.619 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -911705984 INR |
| Levered Free Cash Flow (ttm) | 78.2M INR |
Profile of Morepen Laboratories Limited
| Country | India |
| State | N/A |
| City | Gurugram |
| Address | Tower C, DLF Cyber Park |
| ZIP | 122016 |
| Phone | 91 12 4489 2000 |
| Website | https://www.morepen.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Morepen Laboratories Limited operates as a pharmaceutical and healthcare products company in India. The company manufactures active pharmaceutical ingredients (APIs), home diagnostics, formulations, and over the counter products. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic drugs, anti- coagulant, anti-gout, and anti- malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, blood glucose test strips, and heat belt. It also provides Burnol, first degree/minor burns cream; Fiber-X, a sat isabgol; fever X for fever; Pain X for pain; Acidity X for acidity; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti- allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers its over-the-counter products under the Dr. Morepen brand. It also exports its products. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Q&A For Morepen Laboratories Limited Stock
What is a current MOREPENLAB.NS stock price?
Morepen Laboratories Limited MOREPENLAB.NS stock price today per share is 43.4 INR.
How to purchase Morepen Laboratories Limited stock?
You can buy MOREPENLAB.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Morepen Laboratories Limited?
The stock symbol or ticker of Morepen Laboratories Limited is MOREPENLAB.NS.
Which industry does the Morepen Laboratories Limited company belong to?
The Morepen Laboratories Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Morepen Laboratories Limited have in circulation?
The max supply of Morepen Laboratories Limited shares is 511.72M.
What is Morepen Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Morepen Laboratories Limited PE Ratio is 28.93333400 now.
What was Morepen Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Morepen Laboratories Limited EPS is 1.5 INR over the trailing 12 months.
Which sector does the Morepen Laboratories Limited company belong to?
The Morepen Laboratories Limited sector is Healthcare.